Loading...
FACTS 001: Characteristics of Participants Enrolled in a Phase III Randomised Controlled Trial of Tenofovir Gel for Prevention of HIV-1 and HSV-2
FACTS 001: Characteristics of Participants Enrolled in a Phase III Randomised Controlled Trial of Tenofovir Gel for Prevention of HIV-1 and HSV-2
Delany-Moretlwe, Sinead Smith, Emilee Myer, Landon Ahmed, Khatija Nkala, Busi Maboa, Rebone Gama, Cynthia Sibiya, Sydney Sebe, Modulakgotla Brumskine, William
Delany-Moretlwe, Sinead
Smith, Emilee
Myer, Landon
Ahmed, Khatija
Nkala, Busi
Maboa, Rebone
Gama, Cynthia
Sibiya, Sydney
Sebe, Modulakgotla
Brumskine, William
Abstract
Description
Date
2014
Journal Title
Journal ISSN
Volume Title
Publisher
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
Tenofovir Gel , Controlled Trial , Prevention , HIV-1 , HSV-2 , Randomised controlled trial
Citation
Delany-Moretlwe Sinead, Smith Emilee, Myer Landon, Ahmed Khatija, Nkala Busi, Maboa Rebone, Gama Cynthia, Sibiya Sydney, Sebe Modulakgotla, Brumskine William, Bekker Linda-Gail, Nchabeleng Maposhane, Lombard Carl, Gray Glenda, Rees Helen, and FACTS 001 Study Group. AIDS Research and Human Retroviruses. October 2014, 30(S1): A281-A282. doi:10.1089/aid.2014.5637.abstract.